Yao L - Search Results

1

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.

Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J, Wang L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Sun J, et al. Among authors: yao l. Clin Cancer Res. 2017 Oct 15;23(20):6113-6119. doi: 10.1158/1078-0432.CCR-16-3227. Epub 2017 Jul 19. Clin Cancer Res. 2017. PMID: 28724667

2

[Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer].

Wang Y, Yao L, Liu YQ, Xu Y, Ou YT, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT. Wang Y, et al. Among authors: yao l. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):511-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029694 Chinese.

3

RAD51C germline mutations in Chinese women with familial breast cancer.

Pang Z, Yao L, Zhang J, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Pang Z, et al. Among authors: yao l. Breast Cancer Res Treat. 2011 Oct;129(3):1019-20. doi: 10.1007/s10549-011-1574-3. Epub 2011 May 20. Breast Cancer Res Treat. 2011. PMID: 21597919 No abstract available.

4

Breast cancer subtypes and survival in chinese women with operable primary breast cancer.

Li ZS, Yao L, Liu YQ, Ouyang T, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT. Li ZS, et al. Among authors: yao l. Chin J Cancer Res. 2011 Jun;23(2):134-9. doi: 10.1007/s11670-011-0134-z. Chin J Cancer Res. 2011. PMID: 23482992 Free PMC article.

5

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.

Wu L, Yao L, Zhang H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Yin CC, Xie Y. Wu L, et al. Among authors: yao l. Oncotarget. 2016 Jan 26;7(4):5042-52. doi: 10.18632/oncotarget.5837. Oncotarget. 2016. PMID: 26573232 Free PMC article.

6

Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer.

Yao L, Zhang J, Liu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Yao L, et al. Chin J Cancer Res. 2015 Dec;27(6):553-61. doi: 10.3978/j.issn.1000-9604.2015.12.03. Chin J Cancer Res. 2015. PMID: 26752929 Free PMC article.

7

Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.

Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Yao L, et al. Breast Cancer Res Treat. 2016 Apr;156(3):441-445. doi: 10.1007/s10549-016-3766-3. Epub 2016 Mar 31. Breast Cancer Res Treat. 2016. PMID: 27033093

8

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.

Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Zhang J, et al. Among authors: yao l. Breast Cancer Res Treat. 2016 Aug;158(3):455-62. doi: 10.1007/s10549-016-3902-0. Epub 2016 Jul 8. Breast Cancer Res Treat. 2016. PMID: 27393621

9

Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.

Sheng S, Xu Y, Guo Y, Yao L, Hu L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Sheng S, et al. Among authors: yao l. Int J Cancer. 2020 Jan 15;146(2):487-495. doi: 10.1002/ijc.32424. Epub 2019 Jun 4. Int J Cancer. 2020. PMID: 31119730

10

BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.

Meng H, Yao L, Yuan H, Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Meng H, et al. Among authors: yao l. Int J Cancer. 2020 Jun 1;146(11):3044-3052. doi: 10.1002/ijc.32877. Epub 2020 Feb 22. Int J Cancer. 2020. PMID: 31957001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,882 results

Search Page

Filters